REZOLUTE, INC. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
REZOLUTE, INC. (RZLT) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $0 for the 12-month period ending 2014-06-30, per its 10-K filed 2014-09-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2014-09-30
- REZOLUTE, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2014-06-30 was $0.00.
- REZOLUTE, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- REZOLUTE, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2013-12-31 was $0.00.
- REZOLUTE, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2013-09-30 was $0.00.
- REZOLUTE, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- REZOLUTE, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2013 was $13.00K.
- REZOLUTE, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2011 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 36 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 39 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 42 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 45 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 48 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | $0.00 derived: sum of 2 quarters · filed 2014-09-30 | $0.00 derived: sum of 3 quarters · filed 2014-09-30 | $0.00 10-K · filed 2014-09-30 | |||||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-09-30 | $13.00K 10-Q · filed 2014-05-14 | ||||
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-13 | $0.00 10-Q · filed 2014-02-13 | $0.00 derived: sum of 3 quarters · filed 2014-09-30 | $13.00K derived: sum of 4 quarters · filed 2014-09-30 | $13.00K 10-Q · filed 2014-02-13 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-09-30 | $13.00K derived: sum of 3 quarters · filed 2014-09-30 | $13.00K derived: sum of 4 quarters · filed 2014-09-30 | $13.00K 10-Q · filed 2013-11-12 | ||||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | $13.00K derived: sum of 2 quarters · filed 2014-09-30 | $13.00K derived: sum of 3 quarters · filed 2014-09-30 | $13.00K 10-K · filed 2014-09-30 | $13.00K 10-K · filed 2013-09-11 | ||||
| 2013-03-31 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14 | $13.00K derived: sum of 2 quarters · filed 2014-05-14 | $13.00K 10-Q · filed 2014-05-14 | $13.00K 10-Q · filed 2013-05-15 | |||||
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-13 | $0.00 10-Q · filed 2014-02-13 | |||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | ||||||||
| 2012-06-30 | $0.00 10-K · filed 2013-09-11 | ||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | ||||||||
| 2011-12-31 | $0.00 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |